Mednet is now part of the Launchit Ventures Group. Learn more >

Mednet Reports

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - 2012 Kidney Week of the American Society of Nephrology (ASN)

Options for Iron Correction and Erythropoiesis Stimulation: Better Benefit:Risk Through Individualized Therapy

San Diego, California / October 30 - November 4, 2012

San Diego - More sophisticated strategies for the treatment of anemia in patients with chronic kidney disease (CKD), including those on dialysis, are being driven by new options for replenishing iron and stimulating erythropoiesis. The...

PRIORITY PRESS - 2012 Kidney Week of the American Society of Nephrology (ASN)

Halting Threat of Kidney Failure by Hemolytic Uremic Syndrome and Other Thrombotic Microangiopathies

San Diego, California / October 30-November 4, 2012

San Diego - Two-year results with a targeted monoclonal antibody (MAb) against the complement protein C5 demonstrated that the kidney damage caused by atypical hemolytic uremic syndrome (aHUS) and shiga-toxin producing Escherichia coli HUS...

PRIORITY PRESS - 65th Annual Meeting of the Canadian Cardiovascular Society

Effective Event Reduction in the Era of New Oral Anticoagulants: Pursuing Options

Toronto, Ontario / October 27-31, 2012

Toronto - After 50 years of warfarin use for stroke prevention in atrial fibrillation (AF), there are now 3 new oral anticoagulants equal to, or better than warfarin for stroke prevention. Importantly, they are safer than warfarin in terms...

PRIORITY PRESS - 2012 Canadian Hypertension Congress

Optimal Control of Hypertension: From Lifestyle Modifications to Fixed-Dose Combinations

Toronto, Ontario / October 25-28, 2012

Toronto - Over 1000 patients in Canada are diagnosed with hypertension each day. Best treatment plan depends on factors including severity of high blood pressure (BP), age, comorbidities, as well as, patient and physician preference. Common...

PRIORITY PRESS - 2012 Canadian Hypertension Congress

A Template for Improved Blood Pressure Control and Better Adherence: Integrating Third Generation b-blockers and Single-pill Multiple Mechanism Combinations

Toronto, Ontario / October 25-28, 2012

Toronto - For the prevention, diagnosis and treatment of high blood pressure (BP), the Canadian Hypertension Education Program (CHEP) guidelines provide a template against which physicians can tailor antihypertensive regimens according to...

MEDICAL FRONTIERS - 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

Expansion of MS Therapies: Multicentre Phase III Trials of First-Line Oral Agents

Lyon, France / October 10-13, 2012

Lyon - Oral therapies for the control of multiple sclerosis (MS) are poised to proliferate, based on data presented at the 2012 ECTRIMS. Phase III trials have associated several agents with high rates of efficacy both in regard to the risk...

MEDICAL FRONTIERS - 15th Annual Canadian Diabetes Association (CDA)/ Canadian Society of Endocrinology & Metabolism (CSEM) Professional Conference and Annual Meeting

Inhibiting Kidney Glucose Reabsorption: A Novel Insulin-independent Therapy in Type 2 Diabetes Mellitus

Vancouver, BC / October 10-13, 2012

Vancouver - New updated guidelines on the management of type 2 diabetes mellitus are expected early in 2013. A preview of the new guidelines indicates that glycemic targets may be relaxed in select patients and that the individualized...

PRIORITY PRESS - 48th Annual Meeting of the European Association for the Study of Diabetes

Targeting the Kidney in the Treatment of Diabetes and Associated Cardiovascular Risk Factors

Berlin, Germany / October 1-5, 2012

Berlin - Barriers to effective type 2 diabetes mellitus treatment include risk of hypoglycemia and weight gain, which may be associated with an increased risk of mortality and cardiovascular (CV) events. The new class of selective sodium...

ABSTRACTS in PERSPECTIVE - Based on presentations from the 48th Annual Meeting of the European Association for the Study of Diabetes (EASD)

Weighing Benefits of SGLT2 Inhibition in Type 2 Diabetes Mellitus

Berlin, Germany / October 1-5, 2012

EDITORIAL OVERVIEW: David C. W. Lau, MD, PhD, FRCPCEditor-in-Chief, Canadian Journal of DiabetesProfessor of Medicine, Biochemistry & Molecular BiologyJulia McFarlane Diabetes Research CentreUniversity of CalgaryCalgary, AlbertaRonald...

PRIORITY PRESS - 37th European Society of Medical Oncology Congress (ESMO)

Exploring Benefits of Multitargeted Therapy for Metastatic Colorectal Cancer and Gastrointestinal Stromal Tumours

Vienna, Austria / September 28 – October 2, 2012

Vienna - Progress continues to occur in the treatment of metastatic colorectal cancer. Improved recognition of the complexities of tumour signalling networks have led to the realization that inhibition of a single pathway is unlikely to...

PAGE 17 OF 110   ... 11 12 13 14 15 16 17 18 19 20 ...
All Rights Reserved - Mednet Inc.
Launchit Ventures
Mednet Inc. is part of the Launchit Ventures Group